bg-img9.jpg
8.jpg
The Evolution of Public Health Research—A Summary of the Blog Series

Over the past year, we presented a series of blog posts on The Evolution of Public Health Research, our salute to a profession and area of study that has not only saved many, many millions of lives, but also dramatically improved the length and quality of life as well.

Content: eBook, Topic: Public Health Research, The..........

"Validation" or "Qualification" – What’s the difference?

I face this question on a regular basis from my clients, both internal and external. So what is the difference between qualification and validation?

Topic: Qualification / Validation, Topic: GMP Biol..........

The Evolution of Public Health Research: The Next Frontier

In the first episode of our series, we looked at the cholera epidemic and how public health emerged as a corollary to the germ theory of disease. In this final episode, we arrive at what may be the next frontier in public health research, and once again we are chasing microbes.

Topic: Public Health Research, Content: Blog

Proposed Changes to Biospecimen Consent Requirements Dropped from the Revised Common Rule

If you are conducting biospecimen-based research, you are probably aware that on January 18, the long-anticipated revised Common Rule (Title 45 of the CFR, part 46, Federal Policy for the Protection of Human Subjects) was posted to the Federal Register (for some background on the nature of these revisions, see my blog post).

Topic: Biobanking and Biorepository, Topic: Public..........

Collaboration in Biopharma: Harnessing the Power of Cloud-based Technologies

From banking to e-commerce, cloud computing has transformed the landscape of the world economy. It is also gradually changing the face of the biopharma industry. In the scientific world, effective communication and collaboration are essential to successful outcomes. Although biopharma has been slower than some other industries to adopt cloud-based technologies, the field is increasingly relying on the cloud to advance scientific knowledge.

Topic: Biobanking and Biorepository, Content: Post..........

Biospecimen-Based Research and the 21st Century Cures Act

“God Willing, This Bill Will Save Lives.” So said Vice President Joe Biden, in sharing his thoughts on the potential ramifications of the passing of the 21st Century Cures Act (H.R.6), made possible by the bipartisan leadership of Republicans and Democrats in the Senate and the House on December 13th 2016.

Topic: Cell Therapy Solutions, Topic: GMP Biologic..........

A Perspective on "Expanded Access" to Experimental (Cell) Therapies

“Expanded Access,” is a regulatory pathway for physicians to gain access to experimental therapies for patients who usually do not qualify for the clinical trial. This pathway often represents one final chance against a condition that is severely debilitating and/or fatal. Often called “Compassionate Use,” the number of patients and physicians requesting access to experimental therapies has been growing steadily over the past three decades.

Topic: Cold-Chain Logistics, Topic: Cell Therapy S..........

Entrusting Your Biologics with a Service Provider? Important Factors to Consider

Over the past decade, a wave of scientific advances and new technologies have made significant impacts on how medicines are discovered. The drive towards personalized medicine has led to an increased understanding of the molecular and genetic bases of disease. As a result of this increased knowledge, the life sciences industry is shifting its focus from small molecule medicine to biologic medicine, resulting in increased use of biologics in clinical trials and R&D efforts.

Topic: GMP Biologics Management, Content: Blog

Phacilitate Cell and Gene Therapy World 2017: Streamline the path from discovery to cure


The advancements in cell and gene therapy are increasing at a rapid pace and are transforming the way we think about medicine. Whether in research or in the clinic, scientific innovators are acutely aware that every moment counts when working with these valuable therapies. To facilitate knowledge sharing and collaboration, Thermo Fisher Scientific is proud to support Phacilitate Cell & Gene Therapy World 2017 as the Platinum Sponsor.

Topic: Cell Therapy Solutions, Content: Blog

The Evolution of Public Health Research: Malaria, Part 2

Malaria Elimination vs. Eradication, and Genetic Diversity vs. “Freezer Epidemiology”

It is because of its historic mission to eliminate malaria that the CDC is in Atlanta, Georgia. The agency is still deeply involved with the control of malaria, by providing technical assistance around the world, and continuing to protect the US population from the parasite. The CDC estimates that 1,500 people in the USA annually are infected with malaria while traveling, and the CDC tracks these cases and advises the medical community on accurate diagnosis and treatment.

Topic: Public Health Research, The Evolution of Pu..........

Fisher BioServices Top Five Most Popular Blogs of 2016

2016 has been a year filled with new discoveries in the health and medical R&D space. Through our blog, we have shared great stories of our customers' work and discussed a wide-breadth of topics, focusing on cell therapies, biological material, and public health research.

Content: Blog

The Evolution of Public Health Research: Malaria, Part 1

Mosquitoes, the Military, and Why the CDC is in Atlanta

To most of us in the US, malaria is a health problem restricted to distant parts of the globe. Even in the international media, the disease receives little attention. However, it has only been since 1949 that Malaria was declared “eliminated” in the US.

Topic: Public Health Research, The Evolution of Pu..........